Who are the top shareholders of the Hipolin?

The top shareholder of Hipolin is Kinnari Vaibhav Shah, owning 18.75%, with promoters holding a total of 39.76% pledged shares. Public shareholders include Arunaben Manherlal Vakil at 1.65%, while individual investors collectively hold 23.17%, and there are no mutual funds or foreign institutional investors involved.

The top shareholders of Hipolin primarily consist of promoters, with Kinnari Vaibhav Shah holding the largest share at 18.75%. The promoters collectively have a pledged holding of 39.7627%. In terms of public shareholders, Arunaben Manherlal Vakil is the highest individual shareholder, owning 1.65%. Additionally, individual investors collectively hold 23.17% of the company. Notably, there are currently no mutual funds or foreign institutional investors (FIIs) holding shares in Hipolin.

What does Hipolin do?

Hipolin Ltd is a micro-cap company in the FMCG sector, incorporated in 1994, with recent quarterly results showing net sales of 4 Cr and a net loss of 2 Cr as of March 2025. The company has a market cap of Rs 28 Cr and key metrics include a debt-equity ratio of 0.22 and a return on equity of -40.05%.

Overview:<BR>Hipolin Ltd operates in the Fast-Moving Consumer Goods (FMCG) sector and is categorized as a micro-cap company.<BR><BR>History:<BR>Hipolin was incorporated on 31 March 1994. The company has not reported any significant status changes since its incorporation. The latest quarterly results indicate net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 4 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: -2 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 28 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 54 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.22 <BR>Return on Equity: -40.05% <BR>Price to Book: 3.48<BR><BR>Contact Details:<BR>Address: A/1/1 Nilkanth Indus Estate, Sanand - Viramgam Highway Virochannagar Gujarat : 382170 <BR>Tel: 91-2717-284202 <BR>Email: hipolin@hipolin.com <BR>Website: http://www.hipolin.com

Has Hipolin declared dividend?

Hipolin Ltd has declared a 10% dividend, amounting to 1.0000 per share, but the dividend yield is 0%. While recent short-term returns are negative, long-term returns have shown significant growth.

Hipolin Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1.0000<BR>- Ex-date: Sep-23-2010<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -48.32%, the dividend return was 0%, resulting in a total return of -48.32%.<BR><BR>For the 1-year period, the price return was -29.69%, the dividend return was 0%, leading to a total return of -29.69%.<BR><BR>Over the 2-year period, the price return was -2.0%, the dividend return was 0%, which resulted in a total return of -2.0%.<BR><BR>In the 3-year period, the price return was 139.02%, the dividend return was 0%, culminating in a total return of 139.02%.<BR><BR>For the 4-year period, the price return was 159.41%, the dividend return was 0%, resulting in a total return of 159.41%.<BR><BR>In the 5-year period, the price return was 375.47%, the dividend return was 0%, leading to a total return of 375.47%.<BR><BR>Overall, while Hipolin Ltd has declared a dividend, the dividend yield is 0%, indicating that the dividend does not contribute to the returns in recent periods. The total returns show significant fluctuations, with strong positive returns over longer periods despite negative returns in the short term.

Who are the peers of the Hipolin?

Hipolin's peers include Hind. Unilever, ITC, Nestle India, and Britannia Inds., among others. Hipolin has below-average management risk, growth, and capital structure, with the lowest 1-year return at -32.35% compared to its peers.

Peers: The peers of Hipolin are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Chothani Foods, Novateor Resear., Indong Tea Co, and BKV Industries.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever and Godrej Consumer. Below Average management risk is present at Hipolin, Chothani Foods, Novateor Resear., Indong Tea Co, and the rest. Growth is Average at Nestle India, while Below Average growth is noted for Hind. Unilever, ITC, Britannia Inds., Godrej Consumer, Hipolin, Chothani Foods, Novateor Resear., Indong Tea Co, and the rest. Excellent capital structure is seen at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, while Below Average capital structure is noted for Hipolin, Chothani Foods, Novateor Resear., Indong Tea Co, and the rest.<BR><BR>Return Snapshot: Chothani Foods has the highest 1-year return at 29.06%, while Hipolin has the lowest at -32.35%, indicating that Hipolin's performance is significantly worse than its peers. Additionally, the six-month return is negative for Hipolin, Hind. Unilever, ITC, Godrej Consumer, Chothani Foods, Indong Tea Co, and BKV Industries.

Is Hipolin overvalued or undervalued?

As of April 25, 2023, Hipolin is considered risky and overvalued due to its negative PE ratio of -8.55, poor returns on capital and equity, and significant underperformance compared to industry peers and the Sensex.

As of 25 April 2023, Hipolin's valuation grade has moved from does not qualify to risky, indicating a significant deterioration in its financial health. The company is currently overvalued, as evidenced by its negative PE ratio of -8.55 and an EV to EBITDA ratio of -8.97, which are starkly unfavorable compared to industry peers. Additionally, Hipolin's ROCE stands at -34.00% and ROE at -40.05%, reflecting substantial inefficiencies in generating returns.<BR><BR>In comparison to its peers, such as Hindustan Unilever with a PE ratio of 53.88 and Nestle India at 75.2, Hipolin's financial metrics are alarmingly poor. The EV to Sales ratio of 1.38 also suggests that investors are paying a premium for a company that is struggling to generate profits. Notably, Hipolin's stock has underperformed significantly against the Sensex, with a year-to-date return of -43.47% compared to the Sensex's 5.63%, reinforcing the perception of overvaluation.

What is the technical trend for Hipolin?

As of June 2, 2025, Hipolin's technical trend is mildly bearish, with mixed signals from various indicators, including bearish moving averages and Bollinger Bands, contrasted by some mildly bullish weekly indicators.

As of 2 June 2025, the technical trend for Hipolin has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish, suggesting mixed signals across time frames. The Bollinger Bands are bearish on both weekly and monthly charts, and daily moving averages also reflect a bearish trend. The KST shows a mildly bullish weekly outlook but is mildly bearish monthly, and Dow Theory indicates a mildly bearish weekly stance with a mildly bullish monthly view. The OBV is mildly bearish weekly but bullish monthly, adding to the mixed signals. Overall, the current technical stance is mildly bearish, driven primarily by bearish moving averages and Bollinger Bands, despite some mildly bullish indicators on the weekly time frame.

Who are in the management team of Hipolin?

As of March 2023, the management team of Hipolin includes Shaileshkumar Jayantilal Shah (Chairman/Executive Director), Daxesh B Shah, Samir Rohit Shah, Dimpal Sheth (Executive Directors), and several Independent Non-Executive Directors: Nitaben Bharatbhai Shah, Ajay R. Gandhi, Umesh P. Mehta, and Avni Chouhan. This diverse team oversees the company's governance and strategic direction.

As of March 2023, the management team of Hipolin includes the following individuals:<BR><BR>1. Shaileshkumar Jayantilal Shah - Chairman / Executive Director<BR>2. Daxesh B Shah - Executive Director<BR>3. Samir Rohit Shah - Executive Director<BR>4. Nitaben Bharatbhai Shah - Independent Non-Executive Director<BR>5. Ajay R. Gandhi - Independent Non-Executive Director<BR>6. Umesh P. Mehta - Independent Non-Executive Director<BR>7. Dimpal Sheth - Executive Director<BR>8. Avni Chouhan - Independent Non-Executive Director<BR>9. Avni Chouhan - Additional Independent Director<BR><BR>This team comprises a mix of executive and independent directors, contributing to the governance and strategic direction of the company.

How big is Hipolin?

As of 23rd July, Hipolin Ltd has a market capitalization of 35.00 Cr and reported net sales of 21.57 Cr with a net loss of 3.26 Cr over the last four quarters. Shareholder's funds are 11.42 Cr, and total assets are valued at 16.28 Cr as of March 2024.

As of 23rd July, <BR><BR>Market Cap: Hipolin Ltd has a market capitalization of 35.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 21.57 Cr, while the sum of Net Profit for the same period reflects a loss of 3.26 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 11.42 Cr and Total Assets valued at 16.28 Cr.

When is the next results date for Hipolin?

The next results date for Hipolin is 14 November 2025.

The next results date for Hipolin is scheduled for 14 November 2025.

Are Hipolin latest results good or bad?

Hipolin's latest financial results are concerning, showing a significant decline in Profit Before Tax and Profit After Tax, with both metrics falling sharply compared to previous quarters. Despite a slight improvement in consolidated net profit, the overall financial health remains weak, highlighted by negative operating profit margins and declining net sales.

Hipolin's latest financial results indicate a challenging situation for the company. For the quarter ending March 2025, the Profit Before Tax (PBT) was reported at Rs -2.48 crore, which represents a significant decline of 598.6% compared to the average PBT of the previous four quarters. Similarly, the Profit After Tax (PAT) also fell sharply to Rs -2.36 crore, a staggering drop of 790.6% from the previous average.<BR><BR>The operating performance has also deteriorated, with Operating Profit (PBDIT) at Rs -2.33 crore, marking the lowest point in five quarters, and the Operating Profit Margin at 0.00%, indicating a lack of operational efficiency. Additionally, the Earnings per Share (EPS) fell to Rs -7.54, further underscoring the company's declining profitability.<BR><BR>While there was a slight improvement in the consolidated net profit for the quarter ending June 2025, with a growth of 68.64% compared to the previous quarter, the overall financial health still reflects significant challenges. The net sales showed a decline of 25.68%, and the operating profit margin remained negative, suggesting that the company is still struggling to regain stability.<BR><BR>In summary, the latest results for Hipolin are concerning, with substantial declines in key financial metrics indicating a difficult period for the company.

How has been the historical performance of Hipolin?

Hipolin's historical performance shows increasing net sales from 12.22 Cr in Mar'22 to 21.56 Cr in Mar'25, but rising expenditures have led to negative operating profits and a decline in profitability, with a profit before tax of -3.28 Cr in Mar'25. The company also faces challenges in cash flow, reporting -3.00 Cr from operating activities.

Answer:<BR>The historical performance of Hipolin shows a fluctuating trend in its financial metrics over the past four years.<BR><BR>Breakdown:<BR>Hipolin's net sales have increased from 12.22 Cr in Mar'22 to 21.56 Cr in Mar'25, indicating a positive growth trajectory. However, total expenditure has also risen significantly, from 13.46 Cr in Mar'22 to 24.88 Cr in Mar'25, leading to a negative operating profit (PBDIT) of -3.32 Cr in Mar'25, compared to -1.24 Cr in Mar'22. The company reported a profit before tax of -3.28 Cr in Mar'25, down from a profit of 7.63 Cr in Mar'23, reflecting a substantial decline in profitability. The total assets decreased from 16.28 Cr in Mar'24 to 12.98 Cr in Mar'25, while total liabilities also fell from 16.28 Cr to 12.98 Cr in the same period. Cash flow from operating activities has remained negative, with -3.00 Cr reported in Mar'25, indicating ongoing challenges in generating cash from operations. Overall, while Hipolin has shown growth in sales, it faces significant challenges in managing costs and profitability.

Should I buy, sell or hold Hipolin?

Why is Hipolin falling/rising?

As of 13-Dec, Hipolin Ltd's stock price is rising to Rs 57.20, reflecting a 4.99% increase. This short-term gain follows a two-day upward trend, although the stock has seen significant long-term declines of over 64% year-to-date.

As of 13-Dec, Hipolin Ltd's stock price is rising, currently at Rs 57.20, reflecting a change of Rs 2.72 or 4.99% increase. This upward movement can be attributed to several factors. The stock has outperformed its sector by 5.14% today and has been on a gaining streak for the last two days, accumulating a total return of 10% during this period. Additionally, the stock opened with a significant gain of 4.39% today and reached an intraday high of Rs 57.20. <BR><BR>Despite this positive performance, it is important to note that the stock has experienced a substantial decline over longer periods, with a year-to-date drop of 64.07% and a one-year decline of 73.75%. However, the recent short-term gains indicate a temporary recovery phase, even as investor participation has shown signs of falling, with a decrease in delivery volume noted. Overall, the current rise in Hipolin's stock price is primarily driven by recent positive trading performance and market sentiment, despite the backdrop of longer-term declines.

Which are the latest news on Hipolin?